| Authors: |
Frederickx N; Cancer Centre, Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium., Froyen G; Laboratory for Molecular Diagnostics, Jessa Hospital, Hasselt, Belgium.; Faculty of Medicine and Life Sciences, LCRC, University of Hasselt, Hasselt, Belgium., Kamal M; Department of Drug Development & Innovation (D3i), Institut Curie (IC), Paris, France.; IHU PRISM National Precision Medicine Centre in Oncology, Gustave Roussy, Paris, France., Dupain C; Department of Drug Development & Innovation (D3i), Institut Curie (IC), Paris, France., Pallocca M; Institute of Endotypes in Oncology Metabolism and Immunology 'G. Salvatore' (IEOMI-CNR), Naples, Italy., Maetens J; Cancer Centre, Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium., von Bubnoff N; Department of Hematology and Oncology, University Medical Center Schleswig-Holstein (UKSH) and University Cancer Center Schleswig-Holstein (UCCSH), Campus Lübeck, Lübeck, Germany., Ciliberto G; IRCCS National Cancer Institute Regina Elena, Rome, Italy., De Wurstemberger P; Cancer Centre, Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium., Chamoun Morel Z; Advanced Training Office, Institut Curie (IC), Paris, France., Alessandrello R; Innovation & Strategic Futures Area, Agency for Health Quality and Assessment of Catalonia (AQuAS), Barcelona, Spain., McCrary JM; Department of Human Genetics, Hannover Medical School, Hannover, Germany.; Institute of Clinical Genetics and Genomic Medicine, University Hospital of Würzburg & University of Würzburg, Würzburg, Germany., Maes B; Laboratory for Molecular Diagnostics, Jessa Hospital, Hasselt, Belgium.; Faculty of Medicine and Life Sciences, LCRC, University of Hasselt, Hasselt, Belgium., De Maria R; Alleanza Contro il Cancro, Rome, Italy.; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.; Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Nowak F; Health Technologies Institute, Inserm, Paris, France., Castellano-Garcia JM; Innovation & Strategic Futures Area, Agency for Health Quality and Assessment of Catalonia (AQuAS), Barcelona, Spain., Prats C; Innovation & Strategic Futures Area, Agency for Health Quality and Assessment of Catalonia (AQuAS), Barcelona, Spain., Giacomini P; UOSD Medicina di Precisione in Senologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Hebrant A; Cancer Centre, Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium., Raicevic Toungouz G; Cancer Centre, Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium., Van den Bulcke M; Cancer Centre, Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium., Van Valckenborgh E; Cancer Centre, Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium. |
